» Articles » PMID: 1899778

Direct and Indirect Effects in Vaccine Efficacy and Effectiveness

Overview
Journal Am J Epidemiol
Specialty Public Health
Date 1991 Feb 25
PMID 1899778
Citations 92
Authors
Affiliations
Soon will be listed here.
Abstract

In 1915, Greenwood and Yule noted that for valid vaccine efficacy studies, exposure to infection in the vaccinated and the unvaccinated must be equal (Proc R Soc Med 1915;8(part 2):113-94). The direct effect of a vaccine, however, needs to be defined by the protection it confers given a specific amount of exposure to infection, not just a comparable exposure. In this paper, two classes of parameters are distinguished along lines differing from the conventional distinction between efficacy and effectiveness. Efficacy parameters attempt to control for exposure to infection and represent direct effects on individuals. Direct effectiveness parameters represent a mixture of direct effects on individuals and indirect effects in the population.

Citing Articles

Strength and durability of indirect protection against SARS-CoV-2 infection through vaccine and infection-acquired immunity.

Tan S, Rodriguez-Barraquer I, Kwan A, Blumberg S, Park H, Hutchinson J Nat Commun. 2025; 16(1):1090.

PMID: 39881133 PMC: 11779853. DOI: 10.1038/s41467-024-55029-9.


Estimated Effectiveness of Influenza Vaccines in Preventing Secondary Infections in Households.

Grijalva C, Nguyen H, Zhu Y, Mellis A, McGonigle T, Meece J JAMA Netw Open. 2024; 7(11):e2446814.

PMID: 39570586 PMC: 11582933. DOI: 10.1001/jamanetworkopen.2024.46814.


Quantifying indirect and direct vaccination effects arising in the SIR model.

Lin L, Hamedmoghadam H, Shorten R, Stone L J R Soc Interface. 2024; 21(218):20240299.

PMID: 39288818 PMC: 11463228. DOI: 10.1098/rsif.2024.0299.


Effectiveness of mRNA Booster Vaccine Against Coronavirus Disease 2019 Infection and Severe Outcomes Among Persons With and Without Immune Dysfunction: A Retrospective Cohort Study of National Electronic Medical Record Data in the United States.

Sun J, Zheng Q, Anzalone A, Abraham A, Olex A, Zhang Y Open Forum Infect Dis. 2024; 11(2):ofae019.

PMID: 38379569 PMC: 10878052. DOI: 10.1093/ofid/ofae019.


Estimating protection afforded by prior infection in preventing reinfection: applying the test-negative study design.

Ayoub H, Tomy M, Chemaitelly H, Altarawneh H, Coyle P, Tang P Am J Epidemiol. 2023; 193(6):883-897.

PMID: 38061757 PMC: 11145912. DOI: 10.1093/aje/kwad239.